Sensipar Company Profile

17:20 EDT 24th September 2018 | BioPortfolio


News Articles [15 Associated News Articles listed on BioPortfolio]

FDA clears first 2 generics of Sensipar

Sensipar API Insight,2018 [Report Updated: 14022018] Prices from USD $500

IntroductionDelveInsight's, Sensipar API Insight, 2018 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country...

First Sensipar generics approved

The FDA approved generics of Amgen's Sensipar, or cinacalcet hydrochloride, from Cipla and Aurobindo Pharma, creating the fir -More- 

US Launch Of Sensipar Generics May Await Patent Case Even After FDA Approval

Aurobindo remains embroiled in litigation with Amgen on a Sensipar formulation patent, while Cipla settled ahead of  bench trial. Generic...  

Sensipar Generics: US Court Victory, FDA Approval Position Piramal For Launch

Just days after Piramal was one of three generic drug sponsors found not to have infringed a Sensipar formulation patent...  

Sensipar Drug Insight, 2018 [Report Updated: 14022018] Prices from USD $1000

IntroductionDelveInsight's pharmaceuticals report, "Sensipar Drug Insight, 2018" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location....

Lilly, Pfizer, Sanofi lead in patent litigation, report says

The most litigated cases in 2016 and 2017 were over Biogen's MS drug Tecfidera, Amgen's Sensipar and Bristol-Myers Squibb and Pfizer's anticoagulant Eliquis.

Indian drugmakers cashing in on US market as more big-selling drugs gain generic competitors

The approvals of generic Sensipar (cinacalcet) for Indian firms Cipla and Aurobindo Pharma, while providing…

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Sensipar [State of Florida DOH Central Pharmacy]

Sensipar (cinacalcet) Tablets

Sensipar [Amgen, Inc]

These highlights do not include all the information needed to use Sensipar safely and effectively. See full prescribing information for Sensipar. Sensipar (cinacalcet) TabletsInitial U.S. Approval: 20...

PubMed Articles [0 Results]


Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism

The purpose of this research is to study the effects and safety of Sensipar approved by the Food and Drug Administration (FDA) in patients with kidney failure who are being treated with di...

Post Transplant Study

Retrospective chart review to gather information on Sensipar patterns of use and effects on biochemical parameters in renal transplant recipients

A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

Objectives include description of current practices; assessment over time of K/DOQI goals, clinical outcomes, health resource utilization(HRU) and patient reported outcomes (PRO) and the ...

E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events

The purpose of this study is to evaluate the effects of cinacalcet (cinacalcet HCl or Sensipar®/Mimpara®) on cardiovascular events and death in chronic kidney disease (CKD) patients with...

ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism

The purpose of this study is to compare the proportion of chronic kidney disease (CKD) subjects on dialysis receiving Sensipar® and low dose vitamin D or escalating doses of vitamin D alo...

Companies [3 Associated Companies listed on BioPortfolio]

Sensipar® (cinacalcet HCl)

Sensipar® (cinacalcet HCl) is an innovative, first-in-class, oral therapy indicated to treat hyperparathyroidism (excessive levels of parathyroid hormone) caused by chronic kidney disease; it is appr...



NPS Pharmaceuticals

NPS Pharmaceuticals is engaged in the discovery, development and commercialization of therapeutic small molecules and recombinant proteins to treat bone and mineral, gastrointestinal and central nervo...

More Information about "Sensipar" on BioPortfolio

We have published hundreds of Sensipar news stories on BioPortfolio along with dozens of Sensipar Clinical Trials and PubMed Articles about Sensipar for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sensipar Companies in our database. You can also find out about relevant Sensipar Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record